MediNavi AG

MDQ

DE000A3MQRE9

Pharmaceuticals

End-of-day quote Hanseatische Wertpapierboerse Hamburg Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
4.7 ^EUR	-2.08%		-12.96%	-21.67%

2022	MediNavi AG acquired Nordic Swan Pharma Group ApS for Ã‡69.3 million.	CI
2013	MediNavi AG announced that it has received funding.	CI

MediNavi AG acquired Nordic Swan Pharma Group ApS for Ã‡69.3 million.

September 28, 2022

MediNavi AG (HMSE:MDQ) acquired Nordic Swan Pharma Group ApS for Ã‡69.3 million on September 28, 2022.
MediNavi AG (HMSE:MDQ) completed the acquisition of Nordic Swan Pharma Group ApS on September 28, 2022.

Latest news about MediNavi AG

MediNavi AG acquired Nordic Swan Pharma Group ApS for Ã‡69.3 million.	28/22/28	CI
MediNavi AG announced that it has received funding.	11/13/11	CI

Chart MediNavi AG

Duration

Period

More charts

Company Profile

Medinavi AG is a Germany-based company holding company of its wholly-owned MediKompass GmbH, which is the Company's operating subsidiary. MediKompass GmbH operates an Online reverse auction platform in the field of medicine and healthcare. It operates four websites: www.medikompass.de, www.zahngebot.de, www.schoenheitsgebot.de and www.tierartzkosten.de. Those websites enable exchange of services, where doctors have access to patients and patients can choose offers for their conditions, as well as obtain a second medical opinion. Through its websites, the Company operates on the general health market, dental market and cosmetic surgery market. On March 5, 2012, the Company announced establishment of new subsidiary, DocMatch GmbH.

Sector

Pharmaceuticals

More about the company